NCT03610529View on ClinicalTrials.gov

CardioSenseSystem Compared Study Regarding Efficacy and Safety in the Monitoring of ECG

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 30, 2020

Conditions
Cardiac ArrythmiasUnstable AnginaHeart Valve DisordersDisorder of Aorta
Interventions
DEVICE

CardioSenseSystem

CardioSensySystem is a novel wireless ECG monitoring system developed by Novosense AB for monitoring of ECG in health care departments.

DEVICE

Philips Intellivue

Philips Intellivue in an established ECG monitoring system used at the clinical investigational device.

Trial Locations (1)

SE-222 41

VO Thorax o Kärl, Region Skåne, Lund

Sponsors

Lead Sponsor

Novosense AB
All Listed Sponsors
lead

Novosense AB

INDUSTRY

NCT03610529 - CardioSenseSystem Compared Study Regarding Efficacy and Safety in the Monitoring of ECG | Biotech Hunter | Biotech Hunter